Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|April 25, 2008
Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase aKenichi Onda, Takayuki Suzuki, Ryota Shiraki, et al.
Bioorganic & Medicinal Chemistry|July 2, 2005
Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivativesHiroyuki Hisamichi, Ryo Naito, Akira Toyoshima, et al.
Bioorganic & Medicinal Chemistry|November 11, 2009
Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin V2 receptor agonists and discussion of their binding modesIssei Tsukamoto, Hiroyuki Koshio, Masaya Orita, et al.
Journal of Medicinal Chemistry|April 10, 2013
4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitorsTakeshi Hondo, Masaichi Warizaya, Tatsuya Niimi, et al.
Bioorganic & Medicinal Chemistry|June 7, 2008
Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitorsShinya Nagashima, Hiroshi Nagata, Masahiro Iwata, et al.
Bioorganic & Medicinal Chemistry|August 13, 2008
Potent CCR4 antagonists: synthesis, evaluation, and docking study of 2,4-diaminoquinazolinesKazuhiro Yokoyama, Noriko Ishikawa, Susumu Igarashi, et al.
Bioorganic & Medicinal Chemistry|April 10, 2007
Prodrug-based design, synthesis, and biological evaluation of N-benzenesulfonylpiperidine derivatives as novel, orally active factor Xa inhibitorsTsukasa Ishihara, Norio Seki, Fukushi Hirayama, et al.
Antiviral Chemistry & Chemotherapy|November 26, 2008
Binding modes of two novel non-nucleoside reverse transcriptase inhibitors, YM-215389 and YM-228855, to HIV type-1 reverse transcriptaseEiichi Kodama, Masaya Orita, Naoyuki Masuda, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2014
Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor γ among clinically used angiotensin II receptor blockers: drug-target interaction analysesHirotoshi Kakuta, Eiji Kurosaki, Tatsuya Niimi, et al.
ACS Omega|July 31, 2023
Discovery of a Hidden Trypanosoma cruzi Spermidine Synthase Binding Site and Inhibitors through In Silico, In Vitro, and X-ray CrystallographyRyunosuke Yoshino, Nobuaki Yasuo, Yohsuke Hagiwara, et al.
Pageof 4